During the past decade, Stanford Medicine conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Stanford Medicine" #1 sponsor was "Agios Pharmaceuticals, Inc." with 2 trials, followed by "Bayer" with 1 trials sponsored, "Johns Hopkins All Children's Hospital" with 1 trials sponsored, "Rigshospitalet, Denmark" with 1 trials sponsored and "Stanford University" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Stanford Medicine" #1 collaborator was "Aalborg University Hospital" with 1 trials as a collaborator, "Aarhus University Hospital" with 1 trials as a collaborator, "Farabi Eye Hospital" with 1 trials as a collaborator, "Fight for Sight" with 1 trials as a collaborator and "Hamilton Health Sciences Corporation" with 1 trials as a collaborator. Other collaborators include 18 different institutions and companies that were collaborators in the rest 28 trials.

According to Clinical.Site data, the most researched conditions in "Stanford Medicine" are "Chronic Kidney Disease" (1 trials), "Education, Medical, Continuing" (1 trials), "Help-Seeking Behavior" (1 trials), "Non-Transfusion-dependent Alpha-Thalassemia" (1 trials) and "Non-Transfusion-dependent Beta-Thalassemia" (1 trials). Many other conditions were trialed in "Stanford Medicine" in a lesser frequency.

Most popular intervention types in "Stanford Medicine" are "Drug" (4 trials), "Other" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Mitapivat" (2 trials), "Placebo Matching Mitapivat" (2 trials), "Conventional duration (3 months) of anticoagulant therapy" (1 trials), "Docetaxel" (1 trials) and "Finerenone (Kerendia, BAY94-8862)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Stanford Medicine" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Stanford Medicine". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Stanford Medicine, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Stanford Medicine, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".